PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS
"What used to take months—finding a CDMO, verifying capabilities, reaching the right contact—can now be done in minutes."
"The preference for European manufacturers in the US has grown over the past five or six years, driven by the push for geopolitical risk mitigation."
"It is the Massachusetts story — early-stage companies developing great science, commercial giants with a local presence, and financial partnerships that turn ideas into treatments."
"We have recognized the synergies between the life science and tech industries, and have worked to foster relationships that can accelerate therapeutic, medical device and diagnostic development."
PHARMA & LIFE SCIENCES: LATEST ARTICLES
USA Life Sciences: The Amazonification Effect
September 09, 2025
How patient centricity is changing pharma logistics
PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
MACIG 2026 - Pre-Release
Africa has been attracting more diverse and innovative capital flows over recent years. The US, Europe, the Middle East, Japan, and even India are all crowding in, while China maintains its already well-established presence.
Africa has been attracting more diverse and innovative capital flows over recent years. The US, Europe, the Middle East, Japan, and even India are all crowding in, while China maintains its already well-established presence.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
